ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 54 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 208.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $815,000 | -59.4% | 264,900 | -49.2% | 0.08% | -68.0% |
| Q4 2015 | $2,008,000 | +104.9% | 521,700 | +63.8% | 0.26% | +101.6% |
| Q3 2015 | $980,000 | +351.6% | 318,500 | +464.7% | 0.13% | +323.3% |
| Q1 2015 | $217,000 | -1.8% | 56,400 | +173.8% | 0.03% | -41.2% |
| Q3 2013 | $221,000 | -77.0% | 20,600 | -80.1% | 0.05% | -80.2% |
| Q2 2013 | $962,000 | – | 103,700 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,574,060 | $27,874,000 | 1.68% |
| SENZAR ASSET MANAGEMENT, LLC | 798,381 | $3,385,000 | 0.58% |
| Cormorant Asset Management, LP | 850,000 | $3,604,000 | 0.48% |
| Palo Alto Investors LP | 2,135,739 | $9,056,000 | 0.40% |
| Opus Point Partners Management, LLC | 99,959 | $424,000 | 0.34% |
| Granahan Investment Management | 1,582,237 | $6,709,000 | 0.19% |
| Joel Isaacson & Co., LLC | 70,660 | $300,000 | 0.08% |
| MARINER INVESTMENT GROUP LLC | 59,700 | $253,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $318,000 | 0.06% |
| Cornerstone Capital, Inc. | 59,200 | $251,000 | 0.06% |